HIV-1 Env-reactive antibodies isolated from uninfected subjects
| VH | VK/L | |||||||||
| PTID | ID | Isotype | Family | Mutation frequency | CDR3 length | ID | Family | Mutation frequency | CDR3 length | Specificity |
| % | aa | % | aa | |||||||
| 022-3 | H0929 | G3 | 3–23 | 7.7 | 18 | λ0308 | VL1–47 | 0.035 | 11 | gp41 |
| 022-3 | H0931 | G3 | 4–61 | 10.4 | 24 | κ0692 | VK3–15 | 8.6 | 11 | gp41 |
| 022-3 | H1141 | G1 | 3–48 | 7.5 | 17 | λ0378 | VL3–10 | 3.6 | 11 | gp41 |
| C14 | HC14-2 | M | 3–74 | 3.0 | 8 | λC14-2 | VL1–44 | 0.7 | 12 | gp41 |
| VH | VK/L | |||||||||
| PTID | ID | Isotype | Family | Mutation frequency | CDR3 length | ID | Family | Mutation frequency | CDR3 length | Specificity |
| % | aa | % | aa | |||||||
| 022-3 | H0929 | G3 | 3–23 | 7.7 | 18 | λ0308 | VL1–47 | 0.035 | 11 | gp41 |
| 022-3 | H0931 | G3 | 4–61 | 10.4 | 24 | κ0692 | VK3–15 | 8.6 | 11 | gp41 |
| 022-3 | H1141 | G1 | 3–48 | 7.5 | 17 | λ0378 | VL3–10 | 3.6 | 11 | gp41 |
| C14 | HC14-2 | M | 3–74 | 3.0 | 8 | λC14-2 | VL1–44 | 0.7 | 12 | gp41 |